These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 33079039)
1. Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015-2017. Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M Emerg Infect Dis; 2020 Nov; 26(11):2660-2668. PubMed ID: 33079039 [TBL] [Abstract][Full Text] [Related]
2. Clonal spread of serotype 12F ST4846 Ohkusu M; Takeuchi N; Ishiwada N; Ohkusu K J Med Microbiol; 2019 Sep; 68(9):1383-1390. PubMed ID: 31347997 [No Abstract] [Full Text] [Related]
3. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017. Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M Vaccine; 2020 Feb; 38(7):1818-1824. PubMed ID: 31882246 [TBL] [Abstract][Full Text] [Related]
4. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014. Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan. Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777 [TBL] [Abstract][Full Text] [Related]
6. Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan. Chi HC; Hsieh YC; Tsai MH; Lee CH; Kuo KC; Huang CT; Huang YC J Microbiol Immunol Infect; 2018 Jun; 51(3):332-336. PubMed ID: 28082066 [TBL] [Abstract][Full Text] [Related]
7. Potential Impact of Higher-Valency Pneumococcal Conjugate Vaccines Among Adults in Different Localities in Germany. Ellingson MK; Weinberger DM; van der Linden M; Perniciaro S J Infect Dis; 2024 Jun; 229(6):1669-1673. PubMed ID: 38059558 [TBL] [Abstract][Full Text] [Related]
8. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014. Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018. Amin-Chowdhury Z; Collins S; Sheppard C; Litt D; Fry NK; Andrews N; Ladhani SN Clin Infect Dis; 2020 Nov; 71(8):e235-e243. PubMed ID: 31955196 [TBL] [Abstract][Full Text] [Related]
10. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765 [TBL] [Abstract][Full Text] [Related]
11. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes. Amin-Chowdhury Z; Groves N; Sheppard CL; Litt D; Fry NK; Andrews N; Ladhani SN Vaccine; 2021 Apr; 39(14):1997-2004. PubMed ID: 33715901 [TBL] [Abstract][Full Text] [Related]
12. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
13. The rise and fall of pneumococcal serotypes carried in the PCV era. Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425 [TBL] [Abstract][Full Text] [Related]
14. Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines. Dion SB; Major M; Gabriela Grajales A; Nepal RM; Cane A; Gessner B; Vojicic J; Suaya JA Vaccine; 2021 May; 39(22):3007-3017. PubMed ID: 33824041 [TBL] [Abstract][Full Text] [Related]
15. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure. Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A; Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556 [TBL] [Abstract][Full Text] [Related]
16. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan. Yanagihara K; Kosai K; Mikamo H; Mukae H; Takesue Y; Abe M; Taniguchi K; Petigara T; Kaku M Int J Infect Dis; 2021 Jan; 102():260-268. PubMed ID: 33065297 [TBL] [Abstract][Full Text] [Related]
17. Pneumococcal serotype evolution in Western Europe. Tin Tin Htar M; Christopoulou D; Schmitt HJ BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008 [TBL] [Abstract][Full Text] [Related]
18. Whole-Genome Analysis-Based Phylogeographic Investigation of Streptococcus pneumoniae Serotype 19A Sequence Type 320 Isolates in Japan. Nakano S; Fujisawa T; Chang B; Ito Y; Akeda H; Fujita J; Matsumura Y; Yamamoto M; Suga S; Oishi K; Nagao M; Ohnishi M Antimicrob Agents Chemother; 2022 Feb; 66(2):e0139521. PubMed ID: 34930035 [TBL] [Abstract][Full Text] [Related]
19. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290 [TBL] [Abstract][Full Text] [Related]
20. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain. González-Díaz A; Càmara J; Ercibengoa M; Cercenado E; Larrosa N; Quesada MD; Fontanals D; Cubero M; Marimón JM; Yuste J; Ardanuy C Clin Microbiol Infect; 2020 Jun; 26(6):753-759. PubMed ID: 31756452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]